retatrutide moa vs Eloralintide Obesity Therapies from Eli Lilly | Ahmad Bahareth, MD posted on the topic Retatrutide—A Game Changer in Obesity

Novel dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1(736)amide have preserved biological activities in vitro conferring improved glucose-lowering action in vivo

Self-sourcing and self-dosing without medical supervision is strongly discouraged, particularly for autoimmune patients who are often on complex medication regimens

The FDA does not review the safety and efficacy of compounded products, which are custom-made alternatives to brand drugs designed to meet a specific patients needs

An analysis of 1,007 cases

Keeping your calorie intake under control is key to GLP-1 helping you lose weight

doi: 10.7759/cureus.25946, 12